Cover

Germany to Start First Clinical Tests on Coronavirus Vaccine

Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.

“The Paul-Ehrlich-Institut… has authorised the first clinical trial of a vaccine against COVID-19 in Germany,” the regulatory body said in a statement.

It added that approval was the “result of a careful assessment of the potential risk/benefit profile of the vaccine candidate”.

Meanwhile, the United Kingdom will commence with the first vaccine trial on human on Thursday.

(AFP)

Tags

Related Articles

Leave a Reply

WP2Social Auto Publish Powered By : XYZScripts.com
Close